Table 1 Patient demographics, patient-related factors for PEP, use of pancreatic stents and cholangiographic findings for the 3 NFK groups.
From: Efficacy and safety of primary, early and late needle-knife fistulotomy for biliary access
Primary NKF n (%) | Early NKF n (%) | Late NKF n (%) | p | |
|---|---|---|---|---|
Age (years), mean (range) | 71.3 (18–97) | 75.6 (18–96) | 74.9 (30–96) | 0.018** |
Male sex | 59 (48.7%) | 42 (42.4%) | 46 (41.8%) | 0.698 |
PEP risk factors, mean (SD) | 1.428 (0.966) | 1.200 (0.807) | 1.409 (0.951) | 0.287 |
PEP risk factors | ||||
0 | 18 (14.9%) | 20 (20.2%) | 18 (16.4%) | 0.522 |
1 | 49 (40.5%) | 43 (43.4%) | 45 (40.9%) | |
2 | 39 (32.2%) | 32 (32.3%) | 33 (30.0%) | |
3 | 11 (9.1%) | 4 (4.0%) | 12 (10.9%) | |
4 | 4 (3.3%) | 0 | 2 (1.8%) | |
5 | 0 | 0 | 0 | |
6 | 0 | 0 | 0 | |
Cholangiographic findings | ||||
CBD stones | 106 (87.6%) | 58 (58.6%) | 56 (50.9%) | < 0.001*** |
Malignant biliary stricture | 10 (8.3%) | 23 (23.2%) | 34 (30.9%) | < 0.001*** |
Leaks | 2 (1.7%) | 4 (4.0%) | 4 (3.6%) | 0.475 |
Other findings | 3 (1.7%) | 14 (14.1%) | 16 (14.5%) | < 0.001*** |
Pancreatic stents | 0 | 5 (5.1%) | 3 (2.7%) | 0.262 |
